Serial Number | 85583416 |
Word Mark | MOLECULARHEALTH BECAUSE PRECISION MATTERS |
Filing Date | Thursday, March 29, 2012 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, January 13, 2016 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer |
Goods and Services | Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific, technical and research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research ; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others |
Goods and Services | Providing an online database featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols; consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, April 4, 2012 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, April 4, 2012 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, April 4, 2012 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | MOLECULAR HEALTH GMBH |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | HEIDELBERG 69115 DE |
Party Name | Molecular Health AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | 4010 Basel CH |
Event Date | Event Description |
Wednesday, January 13, 2016 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Wednesday, January 13, 2016 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Monday, October 19, 2015 | ASSIGNED TO EXAMINER |
Tuesday, June 2, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, June 2, 2015 | NON-FINAL ACTION E-MAILED |
Tuesday, June 2, 2015 | NON-FINAL ACTION WRITTEN |
Tuesday, May 12, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, May 12, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, April 28, 2015 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Tuesday, October 28, 2014 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Tuesday, October 28, 2014 | INQUIRY TO SUSPENSION E-MAILED |
Tuesday, October 28, 2014 | SUSPENSION INQUIRY WRITTEN |
Wednesday, October 1, 2014 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
Wednesday, August 20, 2014 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Monday, March 31, 2014 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Monday, March 31, 2014 | LETTER OF SUSPENSION E-MAILED |
Monday, March 31, 2014 | SUSPENSION LETTER WRITTEN |
Tuesday, March 18, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, March 18, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, March 14, 2014 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Tuesday, September 17, 2013 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Tuesday, September 17, 2013 | INQUIRY TO SUSPENSION E-MAILED |
Tuesday, September 17, 2013 | SUSPENSION INQUIRY WRITTEN |
Monday, September 9, 2013 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
Thursday, March 7, 2013 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, March 7, 2013 | LETTER OF SUSPENSION E-MAILED |
Thursday, March 7, 2013 | SUSPENSION LETTER WRITTEN |
Thursday, March 7, 2013 | EXAMINER'S AMENDMENT ENTERED |
Thursday, March 7, 2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, March 7, 2013 | EXAMINERS AMENDMENT E-MAILED |
Thursday, March 7, 2013 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, January 31, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, January 31, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, January 22, 2013 | ASSIGNED TO LIE |
Monday, January 21, 2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, January 21, 2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Sunday, July 22, 2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Sunday, July 22, 2012 | NON-FINAL ACTION E-MAILED |
Sunday, July 22, 2012 | NON-FINAL ACTION WRITTEN |
Tuesday, July 10, 2012 | ASSIGNED TO EXAMINER |
Wednesday, April 4, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Monday, April 2, 2012 | NEW APPLICATION ENTERED IN TRAM |